{
    "id": 2874,
    "fullName": "KDR D717V",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "KDR (VEGFR2) D717V lies within the Ig-like C2-type domain 7 of the Kdr (Vegfr2) protein (PMID: 19723655). D717V confers a gain of function to the Kdr (Vegfr2) protein as demonstrated by ligand-independent tyrosine autophosphorylation in cultured cells (PMID: 19723655), and tumor formation in mouse models (PMID: 29588308).",
            "references": [
                {
                    "id": 12199,
                    "pubMedId": 29588308,
                    "title": "Exome Sequencing of Plasma DNA Portrays the Mutation Landscape of Colorectal Cancer and Discovers Mutated VEGFR2 Receptors as Modulators of Antiangiogenic Therapies.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29588308"
                },
                {
                    "id": 217,
                    "pubMedId": 19723655,
                    "title": "KDR activating mutations in human angiosarcomas are sensitive to specific kinase inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19723655"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 3791,
        "geneSymbol": "KDR",
        "terms": [
            "KDR",
            "CD309",
            "FLK1",
            "VEGFR",
            "VEGFR2"
        ]
    },
    "variant": "D717V",
    "createDate": "12/31/2014",
    "updateDate": "02/03/2020",
    "referenceTranscriptCoordinates": {
        "id": 102172,
        "transcript": "NM_002253",
        "gDna": "chr4:g.55102013T>A",
        "cDna": "c.2150A>T",
        "protein": "p.D717V",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 1573,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, cells expressing KDR D717V were sensitive to Sutent (sunitinib) in culture (PMID: 19723655).",
            "molecularProfile": {
                "id": 2698,
                "profileName": "KDR D717V"
            },
            "therapy": {
                "id": 930,
                "therapyName": "Sunitinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 217,
                    "pubMedId": 19723655,
                    "title": "KDR activating mutations in human angiosarcomas are sensitive to specific kinase inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19723655"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 2698,
            "profileName": "KDR D717V",
            "profileTreatmentApproaches": [
                {
                    "id": 379,
                    "name": "VEGFR Inhibitor (Pan)",
                    "profileName": "KDR D717V"
                },
                {
                    "id": 378,
                    "name": "VEGFR2 Inhibitor",
                    "profileName": "KDR D717V"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 102172,
            "transcript": "NM_002253",
            "gDna": "chr4:g.55102013T>A",
            "cDna": "c.2150A>T",
            "protein": "p.D717V",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}